Monte Rosa Therapeutics, Inc. logo

Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

Overview | Financials
Company Name Monte Rosa Therapeutics, Inc.
Symbol GLUE
Currency USD
Price 6.93
Market Cap 425,756,331
Dividend Yield 0%
52-week-range 3.21 - 12.4
Industry Biotechnology
Sector Healthcare
CEO Dr. Markus Warmuth M.D.
Website https://www.monterosatx.com

An error occurred while fetching data.

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven

Related Stocks

Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

TYRA

14 USD

Esperion Therapeutics, Inc. logo

Esperion Therapeutics, Inc.

ESPR

2.19 USD

Belite Bio, Inc logo

Belite Bio, Inc

BLTE

64.12 USD

Regencell Bioscience Holdings Limited logo

Regencell Bioscience Holdings Limited

RGC

4.92 USD

Inotiv, Inc. logo

Inotiv, Inc.

NOTV

4.08 USD

MeiraGTx Holdings plc logo

MeiraGTx Holdings plc

MGTX

6.15 USD

Arcellx, Inc. logo

Arcellx, Inc.

ACLX

75.54 USD

Kodiak Sciences Inc. logo

Kodiak Sciences Inc.

KOD

8.65 USD

Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc.

VRDN

19.03 USD

Financials

Numbers are in millions USD

Numbers are in millions USD